Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam Luijten

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 3, 2008
Application of a metabolizing system as an adjunct to the rat whole embryo cultureMirjam Luijten, Aart Verhoef, Anja Westerman, et al.
Antioxidants & Redox Signaling|December 11, 2012
Oxidative DNA damage and nucleotide excision repairJoost P M Melis, Harry van Steeg, Mirjam Luijten
Critical Reviews in Toxicology|September 14, 2022
Letter to the editor regarding the review article by Yamada et al. (2021) titled "Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)"Petra van Kesteren, Marja Pronk, Harm Heusinkveld, et al.
Environmental and Molecular Mutagenesis|December 29, 2018
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part I: Isolation, structural, genetic, and biochemical characterizationJulie A Cox, Edwin P Zwart, Mirjam Luijten, et al.
Environmental and Molecular Mutagenesis|February 5, 2019
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicalsJulie A Cox, Edwin P Zwart, Mirjam Luijten, et al.
Mutation Research|July 28, 2009
Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approachLya G Hernández, Harry van Steeg, Mirjam Luijten, et al.
Regulatory Toxicology and Pharmacology : RTP|November 27, 2022
Towards achieving a modern science-based paradigm for agrochemical carcinogenicity assessmentGina M Hilton, Raffaella Corvi, Mirjam Luijten, et al.
Frontiers in Toxicology|October 6, 2022
Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case studyMirjam Luijten, R Corinne Sprong, Emiel Rorije, et al.
Mutation Research|July 19, 2011
The role of XPC: implications in cancer and oxidative DNA damageJoost P M Melis, Mirjam Luijten, Leon H F Mullenders, et al.
Toxicologic Pathology|June 29, 2026
New Approach Methodologies (NAMs) for Carcinogenicity EvaluationFrederic Schorsch, Mirjam Luijten, Mark Cronin, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 3, 2008
Application of a metabolizing system as an adjunct to the rat whole embryo cultureMirjam Luijten, Aart Verhoef, Anja Westerman, et al.
Antioxidants & Redox Signaling|December 11, 2012
Oxidative DNA damage and nucleotide excision repairJoost P M Melis, Harry van Steeg, Mirjam Luijten
Critical Reviews in Toxicology|September 14, 2022
Letter to the editor regarding the review article by Yamada et al. (2021) titled "Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)"Petra van Kesteren, Marja Pronk, Harm Heusinkveld, et al.
Environmental and Molecular Mutagenesis|December 29, 2018
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part I: Isolation, structural, genetic, and biochemical characterizationJulie A Cox, Edwin P Zwart, Mirjam Luijten, et al.
Environmental and Molecular Mutagenesis|February 5, 2019
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicalsJulie A Cox, Edwin P Zwart, Mirjam Luijten, et al.
Mutation Research|July 28, 2009
Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approachLya G Hernández, Harry van Steeg, Mirjam Luijten, et al.
Regulatory Toxicology and Pharmacology : RTP|November 27, 2022
Towards achieving a modern science-based paradigm for agrochemical carcinogenicity assessmentGina M Hilton, Raffaella Corvi, Mirjam Luijten, et al.
Frontiers in Toxicology|October 6, 2022
Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case studyMirjam Luijten, R Corinne Sprong, Emiel Rorije, et al.
Mutation Research|July 19, 2011
The role of XPC: implications in cancer and oxidative DNA damageJoost P M Melis, Mirjam Luijten, Leon H F Mullenders, et al.
Toxicologic Pathology|June 29, 2026
New Approach Methodologies (NAMs) for Carcinogenicity EvaluationFrederic Schorsch, Mirjam Luijten, Mark Cronin, et al.
Pageof 12